Paul Tudor Jones’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,600
Closed -$289K 3910
2026
Q1
$289K Buy
5,600
+2,500
+81% +$175K ﹤0.01% 3162
2025
Q4
$286K Sell
3,100
-2,100
-40% -$201K ﹤0.01% 3085
2025
Q3
$386K Buy
+5,200
New +$526K ﹤0.01% 2839
2025
Q2
Sell
-1,900
Closed -$303K 3484
2025
Q1
$303K Sell
1,900
-2,500
-57% -$452K ﹤0.01% 2582
2024
Q4
$816K Buy
+4,400
New +$854K ﹤0.01% 1873
2024
Q3
Sell
-3,200
Closed -$428K 2903
2024
Q2
$428K Buy
+3,200
New +$606K ﹤0.01% 1872
2024
Q1
Sell
-2,000
Closed -$407K 2475
2023
Q4
$407K Sell
2,000
-600
-23% -$97.2K ﹤0.01% 1887
2023
Q3
$516K Buy
2,600
+900
+53% +$227K 0.01% 1664
2023
Q2
$552K Buy
1,700
+400
+31% +$114K 0.01% 1661
2023
Q1
$304K Buy
1,300
+200
+18% +$50.6K ﹤0.01% 1920
2022
Q4
$275K Sell
1,100
-1,200
-52% -$256K 0.01% 1959
2022
Q3
$409K Buy
+2,300
New +$462K 0.01% 1544

Other funds holding INSP

Paul Tudor Jones's INSP Position: Q2 2026 in Review

Paul Tudor Jones increased its Inspire Medical Systems (INSP) stake by 1.1% in Q2 2026, buying an estimated $89K and bringing the position to 169,095 shares worth $7.54M. The position accounts for 0.01% of the portfolio, ranked #1005.

Paul Tudor Jones first reported a position in INSP in Q4 2018 and has held it in 19 quarters since. The position peaked at $14.6M in Q4 2023. 274 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Paul Tudor Jones held 169,095 shares of Inspire Medical Systems worth $7.54M as of Q2 2026.
  • Paul Tudor Jones bought 1,877 Inspire Medical Systems shares in Q2 2026, an estimated $89K.
  • Inspire Medical Systems made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1005 holding.
  • Paul Tudor Jones first reported a position in Inspire Medical Systems in Q4 2018 and has held it in 19 quarters since.
  • Paul Tudor Jones's Inspire Medical Systems position peaked at $14.6M in Q4 2023.
  • 274 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.